Skip to main content
. 2014 Spring;25(1):e8–e13. doi: 10.1155/2014/971546

TABLE 1.

Demographics, mortality and select microbiological investigations among hepatitis B infected (hepatitis B surface antigen-positive) and noninfected (hepatitis B surface antigen-negative) HIV-positive individuals in Northern Alberta, 1982 to 2010*

Demographic characteristic Hepatitis B virus surface antigen status
P
Positive (n=143) Negative (n=2436)
Age at diagnosis, years 32 (28–40) 34 (28–41) 0.2
Age at death, years 41 (35–48) 49 (33–48) 0.8
Years of life after HIV diagnosis 5 (3–8) 5 (3–8) 0.9
Year of HIV identification* 1996 (1989–2001) 1999 (1993–2004) <0.001
Male sex, n (%) 126 (88.1) 1736 (71.3) <0.001
Deceased, n (%) 49 (34.3) 437 (17.9) <0.001
Incarceration, n (%) 26 (19.3) 504 (24.4) 0.2
Ethnicity, n (%)
  Caucasian 88 (61.5) 1314 (53.9) 0.004
  Aboriginal 20 (14.0) 674 (27.7)
  Black 25 (17.5) 351 (14.4)
  Other 6 (4.2) 97 (4.0)
Risk factors§, n (%)
  Needle stick 0 (0.0) 11 (0.45) 1.0
  Transfusion 3 (2.1) 56 (2.3) 1.0
  Vertical 1 (0.7) 13 (0.53) 0.6
  Bisexual 20 (14.0) 245 (10.1) 0.1
  Men who have sex with men (males only) 75 (59.5) 859 (49.5) 0.03
  Injection drug use 39 (27.3) 833 (34.2) 0.09
  Unknown 3 (2.1) 23 (0.94) 0.2
Serology, n (%)
  Anti-hepatitis B surface antigen positive 22 (17.7) 1167 (50.4) <0.001
  Anti-hepatitis B core antibody negative 6 (9.8) 773 (61.6) <0.001
  Anti-hepatitis C virus positive 37 (37.0) 801 (40.0) 0.6
  Hepatitis C virus RNA positive 3 (15.8) 261 (63.7) 0.002
  Anti-hepatitis A virus positive 43 (70.4) 1035 (69.9) 0.9

Data presented as median (interquartile range) unless otherwise indicated.

*

Data collection ended in May 2010;

Denominators may not equal column totals due to missing data or serology testing not being performed;

Calculated using Mann-Whitney test for continuous variables and χ2 or Fisher’s exact test for categorical variables;

§

Risk factor information is not mutually exclusive